TRAF2 and prostate carcinoma: Moreover, analysis of human prostate cancer datasets from TCGA (Cell, Firehose Legacy, and PanCancer) did not reveal a significant positive correlation between KHDC4 or TRAF2 and androgen receptor expression (Supplementary Figure 8B).